---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-025072"
form_type: "8-K"
ticker: "ABT"
cik: "0000001800"
company_name: "ABBOTT LABORATORIES"
filed_at: "2022-02-18T23:59:59+00:00"
generated_at: "2026-06-27T06:40:50.762233+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Abbott recalls Similac infant formula from Sturgis MI plant; reaffirms EPS guidance

## Summary
- Proactive voluntary recall of Similac powder infant formulas from Sturgis, MI facility; primarily US and Canada.
- FY2022 adjusted diluted EPS guidance reaffirmed at at least $4.70.
- Q1 2022 will include one-time specified item for recall expenses (inventory destruction, etc.); amount not yet quantified.
- Company states recall expenses are not expected to have a material impact on consolidated financial statements.

## SEC filing metadata
- accession: 0001104659-22-025072
- form_type: 8-K
- ticker: ABT
- cik: 0000001800
- company_name: ABBOTT LABORATORIES
- filed_at: 2022-02-18T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1800/000110465922025072/0001104659-22-025072-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1800/000110465922025072/tm227088d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-025072
- JSON: https://secwatch.observer/filing/0001104659-22-025072.json
- Plain text: https://secwatch.observer/filing/0001104659-22-025072.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.